alpha-hydroxy-gamma-methylmercaptobutyric acid: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 11427 |
| CHEMBL ID | 2104213 |
| CHEBI ID | 137228 |
| SCHEMBL ID | 167046 |
| MeSH ID | M0052206 |
| Synonym |
|---|
| z94465h1y7 , |
| 2-hydroxy-4-(methylthio) butanoic acid |
| unii-z94465h1y7 |
| butyric acid, 2-hydroxy-4-(methylthio)- |
| butanoic acid, 2-hydroxy-4-(methylthio)- |
| alpha-hydroxy-gamma-(methylthio)butyric acid |
| alimet |
| 2-hydroxy-4-(methylthio)butanoic acid |
| mha-fa |
| hsdb 5700 |
| dl-2-hydroxy-4-methylthiobuttersaeure |
| (+-)-2-hydroxy-4-(methylthio)butyric acid |
| alpha-hydroxy-gamma-methylmercaptobutyric acid |
| 2-hydroxy-4-(methylthio)butyric acid |
| gamma-(methylthio)-alpha-hydroxybutyric acid |
| alpha-hydroxy-gamma-(methylmercapto)butyric acid |
| mha acid |
| (rs)-3-hydroxy-4-(methylthio)buttersaeure |
| desmeninol [inn] |
| einecs 209-523-0 |
| CHEBI:137228 |
| desmeninol |
| 2-hydroxy-4-methylsulfanylbutanoic acid |
| 583-91-5 |
| H0654 |
| 2-hydroxy-4-methylthiobutanoic acid |
| CHEMBL2104213 |
| FT-0612550 |
| AKOS009157403 |
| dl-2-hydroxy-4-methylthio-butanoic acid |
| 2-hydroxy-4-methylthio-butanoic acid, (+/-)- |
| (+/-)-2-hydroxy-4-(methylthio)butyric acid |
| desmeninol [who-dd] |
| desmeninol [hsdb] |
| ONFOSYPQQXJWGS-UHFFFAOYSA-N |
| 2-hydroxy-4-(methylthio)-butanoic acid |
| 2-hydroxy-4-(methylsulfanyl)butanoic acid |
| SCHEMBL167046 |
| W-105391 |
| 2-hydroxy-4-(methylthio)butyricacid |
| LMFA01050480 |
| dl-2-hydroxy-4-(methylthio)butyric acid |
| mfcd00070490 |
| SR-01000944858-1 |
| sr-01000944858 |
| H11809 |
| (+/-)-2-hydroxy-4-(methylthio)butanoic acid |
| 2-hydroxy-4-(methylthio)-butyric acid |
| 4857-44-7 (calcium[2:1] salt) |
| FT-0699945 |
| DTXSID50862236 |
| EN300-103144 |
| Q27295171 |
| A869459 |
| 4-methylsulfanyl-2-oxidanyl-butanoic acid |
| Z788000926 |
| 2-hydroxy-4-(methylthio)butyric acid, tech grade |
| Class | Description |
|---|---|
| thia fatty acid | Any fatty acid having at least one of the chain methylene groups replaced by sulfur. Members of this group are believed to have important pharmacological (antioxidant and antiatherosclerosis) properties. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1130306 | Inhibition of glycolic acid oxidase (unknown origin) assessed as enzyme-mediated reduction of NaDCIP by sodium glycolate after 1 to 3 mins by spectrophotometer analysis | 1979 | Journal of medicinal chemistry, Jun, Volume: 22, Issue:6 | Quantitative structure-activity relationships involving the inhibition of glycolic acid oxidase by derivatives of glycolic and glyoxylic acids. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 40 (23.95) | 18.7374 |
| 1990's | 23 (13.77) | 18.2507 |
| 2000's | 49 (29.34) | 29.6817 |
| 2010's | 47 (28.14) | 24.3611 |
| 2020's | 8 (4.79) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 14 (8.24%) | 5.53% |
| Reviews | 3 (1.76%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 153 (90.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Article | Year |
|---|---|
| Elimination of adverse effects of ethoxyquin (EQ) by methionine hydroxy analog (MHA). Protective effects of EQ and MHA for bitterweed poisoning in sheep. Toxicology letters, Volume: 16, Issue: 1-2 | 1983 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |